Navigation Links
AlloSource Starts Construction on New Campus
Date:5/5/2011

CENTENNIAL, Colo., May 5, 2011 /PRNewswire/ -- AlloSource, a leading developer, processor, and distributor of bone and soft-tissue allografts for use in surgical procedures around the world, broke ground today on a new two-story building addition to their campus.  The construction project, designed by Intergroup Architects and built by The Weitz Company, also includes renovation of more than half of the existing facility.

"From design, to financing, to construction, the preparation for our new campus has been a labor of love for everyone involved since the expansion will further support AlloSource's mission to honor the gift of tissue donation and create new possibilities for patients in need," said Thomas Cycyota, AlloSource President and CEO.  "Additional space will allow us to maximize the impact of each donor. By consolidating our operations onto one campus and expanding our research lab and medical training facility, we will find new ways to better use donated tissue."

In the past year alone, AlloSource's workforce grew by more than 10 percent to support operation and administration development, and the Company expects its workforce to grow again by more than 10 percent in 2011.  

"AlloSource has been a prominent member of the Centennial business community since 2000, and we are proud that the company has decided to further expand its roots here," said Cathy Noon, Mayor of Centennial. "They are a strong contributor to the local economy and will continue to hire local professionals."

A nonprofit organization and one of the nation's premier tissue networks, AlloSource has provided a range of tissue allografts, including bone, skin and joint grafts throughout the country for more than 15 years. Over the last several years, AlloSource has outgrown its original Centennial headquarters and become separated in buildings around the business park.  A new centralized campus was the best solution to the company's growing needs.

"Upon learning more about what AlloSource does to honor the gift of donation and help patients in need with tissue transplants, it was easy to get passionate about the new building design," said Ned White, Intergroup Architects Principal.  "Great projects are the result of outstanding clients and AlloSource has truly been one."

The new building will include laboratory space, testing and research facilities, clean rooms, freezer storage and supply chain support, as well as office space, conference rooms, break rooms, equipment rooms and general storage.  The renovation work to the existing building will include freezer storage, receiving, material management, cleaning and sterilization space.  The Company also planned for future growth, leaving undeveloped space for further expansion.  

"As a tissue bank, AlloSource operates 24/7, so through intensive pre-planning and site coordination, we have ensured there will be no disruptions to operations throughout the project," said Orville Hinerman, Senior Vice President for The Weitz Company.  "We are honored to play a role in building AlloSource's legacy in Colorado and to further their valuable work in tissue donation and transplant."

Construction on AlloSource's new building is expected to be completed in spring 2012, while the existing building renovation is expected to be completed in fall 2012.

About AlloSource

AlloSource is a non-profit company that offers more than 200 precise bone, skin, soft-tissue and custom-machined allografts for use in an array of life-saving and life-enhancing medical procedures. As the world's leader in fresh cartilage tissue used for joint repair and skin allografts to heal severe burns, AlloSource has grown into one of the largest tissue networks in the country with more than 350 employees.  It is the world's largest processor of live cellular bone growth substitutes and delivers unparalleled expertise and customer service to its growing network of surgeons, partners and the country's most reputable organ procurement organizations.   As one of the leading innovators in maximizing tissue donation with the goal of offering optimal solutions for healthcare providers and their patients, AlloSource is recognized by the medical community for its ability to process and provide high quality tissue.   The company is accredited by the American Association of Tissue Banks (AATB) and is headquartered in Centennial, CO. For more information, please visit allosource.org.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.
Thomas Cycyota
https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=89921


'/>"/>
SOURCE AlloSource
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. AlloSource, Tissue Recipient Join Stars of Life Affected by Organ and Tissue Donation Aboard Donate Life Float in 2009 Rose Parade(R)
2. AlloSource Distributes Record Amount of Tissue in 2008
3. AlloSource Named One of Colorados Top Three Healthcare Companies
4. Oncolytics Biotech Inc. Starts Patient Enrolment in U.S. Phase 2 Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin
5. China Sky One Medical, Inc. Starts Production at Newly Acquired Facility and Reaffirms Guidance
6. The Pittsburgh Life Sciences Greenhouse Starts 2009 With Investment Momentum
7. BioCis Pharma Starts Phase IIa Trial in Psoriasis
8. Pierre Fabre Dermatologie Starts Clinical Trials on a Beta-Blocker to Treat Severe Infantile Haemangioma
9. AMT Starts Preregistration Trial for Glybera(TM)
10. KBI Biopharma Starts Cell Line Generation Process under Vendor Network Agreement for PER.C6(R)
11. EMA Starts Formal Review of Glybera(R) Dossier
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... ... April 21, 2017 , ... ... to nourishing a range of emerging bio and technology start-ups, is hosting “Celebration ... 2017. This double event will start with libations and networking at 3:30 p.m. ...
(Date:4/20/2017)... ... April 20, 2017 , ... ... new webinar will explore challenging patient cases when screening for direct oral anticoagulant. ... may be a need for bridging parental anticoagulation especially for those at high ...
(Date:4/20/2017)... 2017  Eli Lilly and Company (NYSE: ... for the prevention of migraine at the American Academy ... April 22-28, 2017, in Boston . ... AAN, including safety and patient outcomes data for galcanezumab ... reduction in monthly migraine headache days among patients with ...
(Date:4/20/2017)... ... April 20, 2017 , ... ... scientific and clinical research community’s growing body of knowledge during its Eighth ... Gracie Theatre and the adjacent Darling Atrium. During the event, undergraduates, graduate students, ...
Breaking Biology Technology:
(Date:4/3/2017)... WASHINGTON , April 3, 2017 /PRNewswire-USNewswire/ ... single-cell precision engineering platform, detected a statistically ... cell product prior to treatment and objective ... highlight the potential to predict whether cancer ... prior to treatment, as well as to ...
(Date:3/30/2017)... -- The research team of The Hong Kong Polytechnic ... by adopting ground breaking 3D fingerprint minutiae recovery and matching technology, ... accuracy for use in identification, crime investigation, immigration control, security of ... ... A research team led by Dr ...
(Date:3/29/2017)... 29, 2017  higi, the health IT company that ... North America , today announced a Series B ... of EveryMove. The new investment and acquisition accelerates higi,s ... to transform population health activities through the collection and ... higi collects and secures data today on behalf ...
Breaking Biology News(10 mins):